Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30250% above fair value
$149.52+3.19 (+2.18%)
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Pharmaceutical Sales — Europe: $10,449M in FY2025, up 2.0% from a year earlier.
Latest, FY2025
10,449
Period ended Dec 31, 2025
Change on a year earlier
+2.0%
10,246 in FY2024
History
10 years
Since FY2016
Sources
10
Documents cited below
Where the FY2025 figure comes from
“|| Europe (1) | 2,725 | 2,801 | 5,525 | 2,384 | 2,551 | 4,935 | 2,675 | 2,839 | 10,449 | 10 | 12”
Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Reported in Form 8-K Supplemental Table 3c / 3b (Pharmaceutical Geographic Sales).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pharmaceutical Sales — Europe ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10,449 | +2.0% | Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗ |
| FY2024 | Dec 31, 2024 | 10,246 | +5.5% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2023 | Dec 31, 2023 | 9,715 | -10.9% | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
| FY2022 | Dec 31, 2022 | 10,906 | +11.5% | Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗ |
| FY2021 | Dec 31, 2021 | 9,780 | +15.7% | Form 8-K (tm235007d1_ex99-1.htm, filed 2023-02-02) ↗ |
| FY2020 | Dec 31, 2020 | 8,455 | -9.2% | Form 8-K (tm2131077d1_ex99-1.htm, filed 2021-10-28) ↗ |
| FY2019 | Dec 31, 2019 | 9,314 | +2.6% | Form 8-K (tm2032785d1_ex99-1.htm, filed 2020-10-27) ↗ |
| FY2018 | Dec 31, 2018 | 9,076 | +6.5% | Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗ |
| FY2017 | Dec 31, 2017 | 8,522 | +10.8% | Form 8-K (a19-3795_1ex99d1.htm, filed 2019-02-01) ↗ |
| FY2016 | Dec 31, 2016 | 7,689 | – | Form 8-K (a18-5152_1ex99d1.htm, filed 2018-02-02) ↗ |
Breakdown
What makes up pharmaceutical Sales — Europe
Cite this data
StockData. (2026). Merck Pharmaceutical Sales — Europe ($M), annual FY2016–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/pharma-geo-europe
See every metric in the Merck KPI table. Data updated Oct 26, 2026.